A comparative study of the levonorgestrel-releasing intrauterine system Mirena® versus the Copper T380A intrauterine device during lactation: Breast-feeding performance, infant growth and infant development

Contraception

Volumn 72, Issue 5, 2005, Pages 346-351

  Shaamash, Ayman H ^a,b   Sayed, Gamal H ^a   Hussien, Mostafa M ^a   Shaaban, Mamdouh M ^a  

^a Assiut University Faculty of Medicine   (Egypt)

^b NONE   (Egypt)

Author keywords

Breast feeding; Infant growth and development; Levonorgestrel releasing intrauterine system

Indexed keywords

LEVONORGESTREL;

ADULT; ARTICLE; BREAST FEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EGYPT; FEMALE; FOLLOW UP; GROWTH; HUMAN; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; LACTATION; NORMAL HUMAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; UNIVERSITY HOSPITAL;

ADULT; BREAST FEEDING; CHILD DEVELOPMENT; CONTRACEPTIVE AGENTS, FEMALE; EGYPT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INTRAUTERINE DEVICES, COPPER; INTRAUTERINE DEVICES, MEDICATED; LACTATION; LEVONORGESTREL; MALE; PROSPECTIVE STUDIES;

EID: 27144511739     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2005.04.004     Document Type: Article

References (36)

1. S.T. Truitt, A.B. Fraser, D.A. Grimes, M.F. Gallo, and K.F. Schulz Combined hormonal versus nonhormonal versus progestin-only contraception in lactation. A Cochrane review abstract: evidence-based medicine reviews based primarily on meta-analysis of controlled clinical trials Posted 07/01/2004 http://search.medscape.com/px/mscpsearch?
2. A.K. Khella, H.I. Fahim, A.H. Issa, D.C. Sokal, and M.A. Gadalla Lactational amenorrhea as a method of family planning in Egypt Contraception 69 2004 317 322
3. World Health Organization (WHO) Task Force for Epidemiological Research on Reproductive Health Progestogen-only contraceptives during lactation: I. Infant growth Contraception 50 1994 35 53
4. World Health Organization (WHO) Task Force for Epidemiological Research on Reproductive Health Progestogen-only contraceptives during lactation: II. Infant development Contraception 50 1994 55 68
5. S. Diaz Contraceptive implants and lactation Contraception 65 2002 39 46
6. F. Pekonen, T. Nyman, P. Lahteenmaki, M. Haukkamaa, and E.M. Rutanen Intrauterine progestin induces continuous insulin-like growth factor-binding protein-1 production in the human endometrium J Clin Endocrinol Metab 75 1992 660 664
7. C.G. Nilsson, P. Lähteenmäki, and T. Luukkainen Sustained intrauterine release of LNG over five years Fertil Steril 45 1986 805 807
8. M. Haukkamaa, and P. Holma Five year clinical performance of the new formulation of the levonorgestrel releasing intrauterine system and serum levonorgestrel concentration with the new formulation compared to that with the original one Leiras Clinical Study Report 1996 [No.02-89532-07]
9. T. Luukkainen Levonorgestrel-releasing intrauterine system Ann N Y Acad Sci 626 1991 43 49
10. Heikkilä M. Insertion of levonorgestrel and copper releasing IUDs during lactation and after abortion and menstruation. Academic dissertation, published by the Steroid Research Laboratory, University of Helsinki. 1983. ISPN 951-99444-1-9KYPAINOKTKA, Helsinki.
11. S. Diaz, M. Pavez, P. Miranda, E.D. Johansson, and H.B. Croxatto Long-term follow-up of women treated with Norplant implants Contraception 35 1987 551 567
12. C.G. Nilsson, and P. Lähteenmäki Plasma prolactin concentration in women treated with low dose combination type oral contraceptives and women using d-norgestrel-releasing intrauterine system Ann Clin Res 10 1978 242 245
13. E. Weiner, A. Victor, and E.D.B. Johansson Plasma levels of d-norgestrel after oral administration Contraception 14 1976 563 570
14. World Health Organization (WHO). Division of Family Health and Division of Mental Health. Protocols for the development and field testing of techniques for monitoring physical growth and psychosocial development. WHO document WHO/MCH/MNH 1986; 86.1.
15. World Health Organization (WHO). Improving access to quality care in family planning: medical eligibility criteria for initiation and continued use of contraceptive methods. 2nd ed. WHO/RHR/00.02. 2000 (Distr.: WHO, 1211 Geneva 27,Switzerland).
16. American College of Obstetrics and Gynecology Breastfeeding: maternal and infant aspects ACOG Educational Bulletin 2000 258
17. Physicians' desk reference 53rd ed. 1999 Medical Economics Inc Montvale (NJ)
18. C.J. McGavigan, and I.T. Cameron The Mirena levonorgestrel system Drugs Today (Barc) 39 2003 973 984
19. M. Labbok, K. Cooney, and S. Coly Guidelines: breastfeeding, family planning, and the lactational amenorrhea method 1994 Institute for Reproductive Health, Georgetown University Washington (DC)
20. Ghaly I, Helmi F, Salah N. Egyptian Infant Growth Curve: prepared by members of Diabetic Endocrine Metabolic Pediatric Unit, Children University Hospital, Cairo University. Results of the First National Conference of Egyptian Infant Growth Curve, held at Cairo University at 11th December 2003.
21. Population reports. IUDs an update 1996; Series B (6):101-35.
22. R.I. Bjarnadottir, H. Gottfredsdottir, K. Sigurdardottir, R.T. Geirsson, and T.O. Dieben Comparative study of the effects of a progestogen-only pill containing desogestrel and an intrauterine contraceptive system in lactating women BJOG 108 2001 1174 1180
23. M.R. Massai, S. Diaz, and E. Quinteros Contraception effectiveness and clinical performance of nestorone implants in postpartum women Contraception 64 2001 369 376
24. D. Reinprayoon, S. Taneepanichskul, and S. Bunyavejchevin Effects of the etonogestrel-releasing contraceptive implant (Implanon) on parameters of breastfeeding compared to those of an intrauterine system Contraception 62 2000 239 246
25. S. Diaz, A. Zepeda, and X. Maturana Fertility regulation in nursing women: XI. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implant and Copper T 380 A Contraception 56 1997 223 232
26. H. Abdelaleem, El M. Abol-Oyoun, and M.M. Shaaban The use of nomegesterol acetate subdermal contraceptive implants, Uniplant, during lactation Contraception 54 1996 281 286
27. L.D. Halderman, and A.L. Nelson Impact of early postpartum administration of progestin-only hormonal contraceptives compared with non-hormonal contraceptives on short-term breastfeeding patterns Am J Obstet Gynecol 186 2002 1250 1258
28. K.I. Kennedy, R. Rivera, and A.S. McNeilly Consensus statement on the use of breastfeeding as a family planning method Contraception 39 1997 477 496
29. E. Guiloff, A. Ibarra-Polo, J. Zanartu, C. Toscanini, T.W. Mischler, and C. Gomez-Rogers Effect of contraception on lactation Am J Obstet Gynecol 118 1974 42 45
30. M. Karim, R. Ammar, S. el-Mahgoub, B. el-Ganzoury, F. Fikri, and I. Abdou Injected progestogens and lactation BMJ 1 1971 200 203
31. J.J. Kelsey Hormonal contraception and lactation J Hum Lact 12 1996 315 318 [review]
32. E.D. Johansson, and R. Sitruk-Ware New delivery systems in contraception: vaginal rings Am J Obstet Gynecol 190 Suppl 4 2004 S54 S59
33. S. Ratchanon, and S. Taneepanichskul Depot-medroxyprogesterone acetate and basal serum prolactin levels in lactating women Obstet Gynecol 96 2002 926 928
34. A. Baheiraei, N. Ardsetani, and S. Ghazizadeh Effects of progestogen-only contraceptives on breastfeeding and infant growth Int J Gynecol Obstet 74 2001 203 205
35. P. Virutamasen, S. Leepipatpaiboon, and R. Kriengsinyot Pharmacodynamic effects of depot-medroxy progesterone acetate administered to lactating women on their male infants Contraception 54 1996 153 157
36. M.M. Shaaban Contraception with progestogens and progesterone during lactation J Steroid Biochem Mol Biol 40 1991 705 710